HARI KRISHNAN KRISHNAN NAIR
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology BATTLE CREEK, MI NPI 1154773836
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology MI Ipsen Biopharmaceuticals, Inc All categories
General Payments — all program years on this page
$2,942.42
- Category: General Payments
- Program years: PY2019–2024
- Record count: 70
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,091.16 across 42 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $891.26 | 40 |
| Education | $199.90 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | $226.69 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $142.59 | 7 |
| Acerta Pharma LLC | $110.19 | 1 |
| Gilead Sciences, Inc. | $70.45 | 2 |
| Genentech USA, Inc. | $52.64 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $43.59 | 2 |
| Celgene Corporation | $42.64 | 3 |
| Merck Sharp & Dohme Corporation | $31.95 | 1 |
| JAZZ PHARMACEUTICALS INC. | $30.54 | 1 |
| TerSera Therapeutics LLC | $23.07 | 1 |
| ARRAY BIOPHARMA INC | $21.52 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $21.44 | 1 |
| ABBVIE INC. | $20.68 | 1 |
| SOBI, INC | $20.67 | 1 |
| SERVIER PHARMACEUTICALS LLC | $20.64 | 1 |
| Incyte Corporation | $20.59 | 1 |
| PharmaEssentia USA Corporation | $20.26 | 1 |
| Myriad Genetic Laboratories, Inc. | $20.04 | 1 |
| EISAI INC. | $19.16 | 1 |
| Emmaus Medical, Inc. | $16.93 | 1 |
| PFIZER INC. | $15.79 | 1 |
| EMD Serono, Inc. | $15.78 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $14.88 | 1 |
| Lilly USA, LLC | $14.86 | 1 |
| Janssen Biotech, Inc. | $14.18 | 1 |
| Mirati Therapeutics, Inc. | $14.12 | 1 |
| Deciphera Pharmaceuticals Inc. | $14.09 | 1 |
| Rigel Pharmaceuticals, Inc. | $11.18 | 1 |
By program year
Records — PY2024 (42)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.